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Mouse teratocarcinoma F9 cells differentiate into primitive endoderm (PrE) when 
treated with retinoic acid (RA) or H2O2 and these changes are accompanied by an up-
regulation of Wnt6 and activation of the canonical WNT/β-catenin pathway. Data from 
our lab shows PrE differentiation is accompanied by an increase in reactive oxygen 
species (ROS), which induces a conformational change in Nucleoredoxin preventing its 
ability to bind and inhibit Dishevelled. This in turn positively impacts on the WNT/β-
catenin signaling pathway leading to differentiation. The source of endogenous ROS seen 
following RA treatment was investigated and members of the NADPH oxidase (NOX) 
family were identified as candidates as Nox1-4 and Duox2 genes are up-regulated by RA. 
This study shows Nox1 and Nox4 are up-regulated when Gata6 is overexpressed in F9 
cells. Furthermore, the pan-NOX inhibitor VAS2870 and NOX1-specific inhibitor 
ML171 significantly reduced the ability of RA to induce PrE differentiation. 
Additionally, a knockdown of Nox1 and/or Nox4 attenuate RA-mediated differentiation. 
Overexpression of Nox1 or Nox4 in F9 cells increases the levels of ROS, however, this is 
not sufficient for differentiation. Thus, the data suggest that the ROS produced during the 
differentiation of F9 cells into PrE is the result of an increase in NOX1 and NOX4 
activity; however, overexpressing Nox1 or Nox4 alone is not sufficient to induce cells to 




F9, Extraembryonic endoderm, Primitive endoderm, WNT, NAPDH oxidase, Reactive 
Oxygen Species, Differentiation, Retinoic Acid  
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1.1 Mouse early development  
 
 Fertilization of mouse eggs occurs in the oviduct, followed by dramatic 
architectural changes to the zygote post implantation [1]. The zygote divides to give rise 
to the blastocyst, which is comprised of both the trophectoderm and inner cell mass 
(ICM) [1]. Cells of the ICM differentiate forming the epiblast, which gives rise to the 
embryo proper and primitive endoderm (PrE), the first extraembryonic endoderm (XEN) 
population of cells [2]. Endoderm is the innermost germ layer of growing embryos and is 
found in all multi-layered embryos [3]. XEN, although endoderm, does not contribute to 
the embryo proper [3]. Cells committed towards PrE express Gata6, FoxA2, and Dab2 
among other genes [3] (Fig. 1.1).  PrE gives rise to two separate cell lineages: parietal 
endoderm (PE) and visceral endoderm (VE) [4]. Cells of the parietal endoderm, which 
migrate to line the trophectoderm, are crucial for protection of the embryo from 
mechanical damage and absorption of nutrients through the formation of the parietal yolk 
sac [4]. Visceral endoderm remains in contact with the epiblast and gives rise to the 
visceral yolk sac [4]. 
 The differentiation of PrE to PE is one of the earliest epithelial-to-mesenchymal 
transitions (EMTs) in the developing mouse embryo [4]. EMTs occur when non-motile 
adherent epithelial cells adopt a migratory fate characteristic of mesenchymal cells. This 
is accomplished through changes in gene expression that lead to the loss of cell-cell 
adhesion, changes in cell polarity, morphology and migration. Loss of E-cadherin is a 
hallmark of an EMT, which destabilizes cell-cell junctions, enabling cell migration [5]. 
Although EMTs play pivotal roles in developmental processes such as gastrulation, 
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Figure 1.1. Mouse early development. In the early blastocyst two cell types are present: 
the inner cell mass (ICM) and the trophectoderm. The ICM is characterized by the 
expression of Oct4 (yellow), Gata6 (purple) and Nanog (red). The ICM gives rise to the 
epiblast, which maintains expression of Nanog and PrE expressing Gata4, 6, Sox7, 17, 
Dab2, and FoxA2. PrE (purple) is the first population of XEN and differentiates into 
either PE (green) cells or VE (purple). PrE cells differentiating to a PE lineage undergo 
an EMT lining the blastocoel surface of the trophectoderm, and are characterized by 
expression of Thrombomodulin. PE cells create the parietal yolk sac. PrE cells 
differentiating to VE cells remain attached to the basement membrane of the ICM and 
form the visceral yolk sac. The extraembryonic endoderm is important for proper 
development of the epiblast as they are responsible for nutrient and waste exchange prior 












1.2 The F9 teratocarcinoma cell line model of mouse 
extraembryonic endoderm differentiation 
 
 The study of extraembryonic endoderm formation in vivo presents unavoidable 
difficulties; e.g., mammalian development occurs in utero, the small size of the embryo at 
these early stages, and the presence of other cell lineages in addition to XEN. To 
circumvent these constraints, investigators use the F9 teratocarcinoma cell line as an in 
vitro model to study XEN differentiation [6]. The F9 cell line was derived from a 
teratoma that formed following grafting 6-day old mouse embryos into the testes of the 
129/J mouse strain [7]. Spontaneous differentiation rarely occurs in F9 cells, but 
differentiation to XEN can be chemically induced [8]. For instance, F9 cells treated with 
retinoic acid (RA) differentiate into PrE and can be further induced to parietal endoderm 
by subsequent treatment with dibutyryl cyclic adenosine monophosphate (db-cAMP) to 
augment Protein Kinase A (PKA) activity [9].  RA, a metabolite of vitamin A, crosses the 
plasma and nuclear membranes to bind the retinoic acid receptor (RAR) and retinoic X 
receptor (RXR) heterodimer [10]. There are three subtypes of RAR (RARα, β, and γ) and 
RXR (RXRα, β, and γ); however, it is the RXRα-RARγ heterodimer that is essential for 
differentiation of F9 cells into PrE [10] In the absence of RA, RAR/RXR heterodimers 
recruit repressive complexes inhibiting transcription [3]. However, this repressive 
complex is exchanged for an activating complex in the presence of RA [3]. RA is 
considered the limiting factor in the activation of the RAR/RXR target genes [3]. 
 Differentiation of F9 cells is accompanied by increased synthesis of extracellular 
matrix proteins, cytokeratins and a loss of stage-specific embryonic antigen (SSEA-1) 
[8]. Increased expression of Keratin-8 (Ker8), encoding an intermediate filament protein, 
and the accumulation of KER8 accompanies F9 cell differentiation [11, 12]. Ker8 is not 
expressed in the inner cell mass, but its expression is characteristic of XEN and the 
trophectoderm [11]. Additionally, an increase in disabled-2 (Dab2) expression is also 
indicative of PrE formation [13]. The differentiation from PrE to PE can be identified by 
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the increase of Thrombomodulin (TM), an endothelial cell receptor [14]. In addition to 
these changes of molecular markers, F9 cells undergo morphological changes and adopt 
large processes and become more rounded as they differentiate [8]. Concurrently, these 
cells migrate from the large colonies that develop in the undifferentiated state [8]. Our lab 
has shown that in addition to these molecular and morphological changes induced by RA, 
differentiation of F9 cells is also accompanied by activation of the canonical WNT/β-
catenin pathway [9], and as described below, this pathway is modulated by Reactive 
Oxygen Species (ROS) [6]. 
 
1.3 Canonical WNT/β-catenin signaling 
 
 WNTs belong to a family of secreted glycoproteins involved in several important 
cellular processes including proliferation, differentiation and migration. There are at least 
three WNT signaling pathways: the canonical WNT/β-catenin pathway and two non-
canonical pathways, WNT/JNK-planar cell polarity (PCP) and WNT/Ca2+. Canonical 
WNT/β-catenin signaling plays an essential role in EMTs during embryonic development 
and is implicated in the progression of cancer [15]. Canonical WNT signaling occurs 
when the WNT ligand binds to and activates a seven-transmembrane Frizzled (FZD) 
receptor. As a result, Dishevelled (DVL) moves to the plasma membrane and recruits 
AXIN away from a destruction complex that, in the absence of the WNT ligand, 
functions via glycogen synthase kinase 3β (GSK-3β) and casein kinase I (CK1) to 
phosphorylate β-catenin, marking it for ubiquitination and degradation in the proteasome. 
However, when WNT is present, β-catenin is not degraded, allowing the latter to 
accumulate in the cytosol and translocate to the nucleus where it binds to and activates 
the T-cell-factors-Lymphoid enhancer factors (TCF-LEF) family of transcription factors. 
Together, β-catenin/TCF-LEF complex impart changes in gene expression resulting in 
the loss of epithelial markers (E-cadherin) and concomitant increase in mesenchymal 
markers (N-cadherin) [6]. Recently, we have found that DVL in undifferentiated F9 cells 
associates with nucleoredoxin (NRX), a redox sensitive protein of the Thioredoxin family 
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[16] that scavenges ROS [17]. This NRX-DVL association in F9 cells has also been 
shown in NIH3T3 murine fibroblast-derived cells and N1E-115 neuroblastoma cells.  
[18]. NRX when bound to DVL inhibits canonical WNT signaling, however, in the 
presence of ROS, NRX dissociates from DVL and the WNT pathway is primed awaiting 
the WNT ligand [17] (Fig 1.2). Support for this redox-sensitive regulation comes from 
NRX knockdown studies that show this is sufficient to increase TCF activity [17]. NRX, 
under oxidizing conditions, forms a disulphide bridge between two cysteine residues of 
the thiol functional group; this allows for changes in protein function and modulates 
protein-protein interactions of NRX [19]. Sandieson et al. (2014) reported using co-
immunoprecipitation that while reduced binding of NRX and DVL occurred in F9 cells 
treated with the H2O2, increased binding was favoured under reducing conditions with 
dithiothreitol [17]. Furthermore, a knockdown of NRX in F9 cells increases β-
catenin/TCF dependent transcription, allowing cells to differentiate to PrE, or to PE if 
treated with db-cAMP [17]. These data show an integral role of the redox sensitive 
protein NRX in F9 cell differentiation. 
 
1.4 Reactive oxygen species 
 
 ROS are classically known as by-products of metabolic processes produced 
through the incomplete reduction of oxygen. There are two groups of ROS; oxygen-
derived radicals, which include superoxide, hydroxyl, peroxyl and alkoxyl and 
nonradicals, which act as oxidizers or are readily converted to radicals such as 
hypochlorous acid, ozone, singlet oxygen and hydrogen peroxide [24]. ROS create 
oxidative stress on cells, damaging nucleic acids, proteins and lipids. This damage is 
linked to age-related and vascular diseases including neurodegeneration and 
atherosclerosis, respectively [20, 21, 22, 23]. Despite the negative aspects of ROS, recent 
studies now show cells benefitting from it to induce biological processes such as 
differentiation, apoptosis and proliferation [6, 20, 24]. ROS affect cell signaling through 
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oxidizing redox-sensitive cysteine residues on proteins, including the aforementioned 
NRX and its effect on the canonical WNT/β-catenin pathway [17, 24]. ROS also effects 
cell proliferation through the activation of the transcription factor nuclear factor kappaB 
[26]. Our lab has recently shown that H2O2 treatment alone is sufficient to induce XEN 
differentiation, showing both morphological and molecular changes similar to those 
accompanying RA-induced PrE formation [6] and interestingly, F9 cells treated with RA 
show elevated ROS levels in the cytosol. Furthermore, ROS is necessary for XEN to 
develop since differentiation is blocked when RA-treated F9 cells are either pre-treated 
with antioxidants to quench the levels of ROS or when diphenyleneiodonium (DPI) is 
used to inhibit NADPH oxidase (NOX) activity [6]. 
 
1.5 NADPH oxidase 
 
 RA-induced differentiation is accompanied and promoted by an increase in the 
levels of ROS [6, 17]. Due to lack of MitoTracker Red probe staining corresponding with 
the ROS indicator CM-H2DCFDA, Wen et al. (2012) concluded that the RA-induced 
ROS is not produced by the mitochondria. The cytosolic source of this ROS was 
investigated and the candidates identified include the members of the membrane bound 
NOX family, which are capable of producing superoxide that is converted to H2O2 by 
superoxide dismutase [6, 25]. NOX proteins were first found in professional phagocytes, 
which use superoxide to combat bacterial infections [24, 27]. Subsequent investigations 
have revealed homologues of the membrane bound cytochrome subunit, now delineating 
four mouse NOX proteins (NOX1, NOX2, NOX3, and NOX4) and two DUOX proteins 
(DUOX1 and DUOX2) [24, 28]. These NOX proteins work in concert with cytosolic 
subunits that include: p22phox, p47phox, p67phox, p40phox, and the small GTP-binding 
proteins RAC1 and RAC2 [24]. NOX1 function is dependent on the membrane subunit 
p22phox, as well as the cytosolic subunits p47phox and p67phox, and evidence exists that Rac 
is required to regulate its activity [24]. NOX4, however, is a p22phox-dependent enzyme, 
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and does not require additional cytosolic subunits or Rac for activation and function [24]. 
NOX proteins have been shown localized to many different membranes including the 
endoplasmic reticulum, caveolae or lipid rafts, phagocytic vacuoles and nucleus [24]. As 
noted above, DPI, presumably acting on all NOX proteins in RA treated F9 cells, blocked 
ROS production and attenuated differentiation [6]. DPI has served as a general NOX 
inhibitor, but because it also acts on other non-NOX flavoenzymes [29], further research 
was done to confirm an integral role for NOX proteins in the RA mediated differentiation 
of F9 cells. 
 There is precedence for NOX proteins being involved in WNT signaling (Fig 1.2) 
and PrE differentiation as Nox1-4 and Duox2 gene expression in F9 cells is upregulated 
following RA treatment [6], and the Nox1 promoter is regulated GATA6, which is 
involved in XEN differentiation [30, 31]. Furthermore, Brewer et al. (2006) reported that 
Gata6 binds directly to the Nox1 proximal promoter and regulates gene expression. 
Whereas overexpressing NOX1 in IEC-6 cells treated with WNT3a increased β-catenin 
protein levels when compared to WNT3a treatment alone [32], increased Nox4 
expression in HEK-293 cells spontaneously increased ROS production without the need 
for additional stimulus [33]. Additionally, NOX1 can post-transcriptionally increase the 
levels of Keratin 18 [34], a fetal-type cytokeratin encoded by transcripts that increase 
during RA-induced F9 cell differentiation [12]. Wen et al. (2012) also show NOX1 to be 
upregulated higher than the other NOX subunits. NOX4 however, has been linked to cell 
proliferation, cytoskeletal reorganization, migration and stem cell differentiation [35, 36, 
37]. Ellmark et al. (2005) showed that an increase in ROS occurs with an increase in 
Nox4 mRNA. For these reasons I have specifically selected NOX1 and NOX4 to 
interrogate as the major candidates involved in the ROS production that is sufficient and 





Figure 1.2. The canonical WNT/β-catenin signaling pathway and the role of ROS. 
When WNT ligand is present it binds to its receptor FZD. DVL then moves to the plasma 
membrane, recruiting AXIN away from the destruction complex, inhibiting GSK3-β from 
marking β-catenin for degradation. However, when NRX is present it inhibits DVL from 
recruiting AXIN inhibiting the WNT/β-catenin pathway. NOX1 generates ROS through 
the activation of Rac1 and when NRX is in the presence of ROS it dissociates from DVL. 
This enables DVL to recruit AXIN in the presence of the WNT ligand. Adapted from 











1.6 Hypothesis and Objectives: 
 
 Given what we know about the redox regulation of the WNT signaling pathway in 
a number of cell types including F9 cells, I hypothesize that the activity of NADPH 
oxidase 1 and/or 4 is/are responsible for producing the ROS that are necessary and 
sufficient to induce F9 cells to differentiate. 
My objectives to address this hypothesis are: 
1. To identify components of the signaling pathway(s) that regulate the expression of 
Nox1 and 4 genes 
2. To determine if NOX1 or 4 activity is necessary for XEN formation 




2. Materials and Methods 
2.1 Cell Culture 
 
Mouse teratocarcinoma F9 cells (ATCC) were cultured in Dulbecco’s modified 
Eagles medium (Lonza), supplemented with 10% fetal bovine serum (Gibco) and 1% 
penicillin-streptomycin (Lonza), and incubated at 37°C and 5% CO2. Cells were treated 
with 10-7 M retinoic acid (RA all-trans; Sigma Aldrich), dimethyl sulfoxide (DMSO; 
Caledon) as a negative control, or 100 µM H2O2. DMSO was the solvent for all 
chemicals used in this study. Cells were treated or co-treated with the pan-NOX inhibitor 
VAS2870 (1 µM) (Sigma) and RA 24 hours after seeding and grown for 3 days. Cells 
were treated or co-treated with the NOX1 specific inhibitor ML171 (250 nM) (Tocris) 
and RA immediately post seeding and grown for 4 days as described above. Cells were 




The following plasmids were transfected into cells for overexpression: 
pcDNA3.1-EV (empty vector) as a transfection control, pcDNA3.1-Gata6; pcDNA-
mNox4 (a gift from Dr. M. Jaconi, University of Geneva), pcDNA3.1-mNox1 (Addgene # 
58340), pRL-TK, a gift from Dr. R. DeKoter (Western University), and pGL3-BARL. The 
following plasmids were transfected into cells for knockdown of target genes: piLenti-
siRNA-GFP-Nox1 “CTATTTAACTTCGAACGCTACAGAAGAAG”, piLenti-siRNA-




“TCCAGTGGTTTGCAGATTTACTCTGTGTG” (Applied Biological Materials, 
Richmond BC). 
 
2.3 Cell Transient Transfection 
 
F9 cells were reverse transfected using the transfection reagent Lipofectamine 
2000 (Life Technologies) according to manufacturer’s recommendations. Approximately 
2.5 x 105 cells were added to a 35 mm dish already containing a total of 4 µg of DNA 
plasmid and 10 µl of Lipofectamine 2000 that were diluted in Opti-MEM reduced serum 
medium (Life Technologies). After 6 h medium was replaced with fresh culture medium 
and cells grew overnight. Approximately 1 x 105 cells were then passaged onto 60 mm 
dishes containing 1.75 mg/ml G418 sulfate (sigma) or 1 µg/ml puromycin, depending on 
the resistance inferred by the vector and grown for 4 days. This selection allowed only 
cells that were transfected and actively transcribing the vector to survive. 
 
2.4 Immunoblot analysis 
 
Immunoblot analysis was used to determine presence or absence, as well as 
relative amount, of protein present in cells at the time of lysis. Protein lysates of cells 
were collected in RIPA buffer containing 150 mM sodium chloride, 1.0 % Triton X-100, 
0.5 % deoxycholate, 0.1 % SDS and 50 mM Tris pH 8.0. Protein concentrations were 
determined using the DCTM Protein Assay (Bio-Rad), and 20 μg of protein lysate was 
mixed 1:2 with 3X SDS loading buffer containing 10 % β-mercaptoethanol and separated 
on 10 % polyacrylamide gels by electrophoresis for 2 h with 100 V at 4°C. Following 
electrophoresis, the proteins were wet-transferred electrophoretically to Immunoblot 
PVDF membrane (Bio-Rad) for 16 h with 20 V at 4°C using a Tris-glycine transfer 
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buffer containing 20 % methanol. Membranes were incubated in Tris buffered saline with 
0.1 % Tween-20 (TBS-T) containing 10% w/v skim milk powder for 1 h shaking at room 
temperature. Membranes were then incubated with primary antibody overnight at 4°C, 
followed by 3 washes 5 min each in TBS-T, incubated with secondary antibody for 2 h at 
room temperature followed by 3 washes for 10 min each in TBS-T. SuperSignal West 
Pico Chemiluminescent Detection Kit (Thermo Scientific) was used to detect the 
presence of secondary antibodies conjugated to horseradish peroxidase (HRP). Signals 
were captured using a Molecular Imager Gel Doc XR system (Bio-Rad) with Quantity 
One Software. The primary antibodies used were directed against TROMA-1 (1:10; 55 
kDa, Developmental Studies Hybridoma Bank) and β-actin (1:10000; 47 kDa, Santa 
Cruz) dissolved in 3 % Bovine Serum Albumin w/v in TBS-T. TROMA-1 targets the 
intermediate filament KER8 found in differentiated F9 cells. β-actin was used as a protein 
loading control. Secondary anti-rat (1:1000) and anti-mouse (1:1000) antibodies were 
HRP-conjugated and dissolved in 3 % skim milk w/v in TBS-T. 
 
2.5 Quantitative reverse transcription polymerase chain reaction 
(qRT-PCR) 
 
qRT-PCR was used to determine relative steady state levels of mRNA in cells. 
Total RNA from treated and/or transfected cells after 4 days of growth was isolated and 
collected using the RNeasy Mini Kit (Qiagen). RNA was reverse transcribed into first 
strand cDNA using the High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems) and the manufacturer's recommendations. The CFX Connect Real-Time 
PCR Detection System (Bio-Rad) was used for qRT-PCR analysis. Each reaction 
contained 500 nM of each primer, SensiFAST SYBR Mix (FroggaBio), and 1 μL of 
cDNA. Primers sequences are listed in Appendix 1. Analysis of steady state mRNA 
levels was determined using the comparative cycle threshold (Δ/ΔCt) method. Steady 
state mRNA levels were normalized to L14 mRNA and relative values were normalized 
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by comparing treatments to DMSO-treated and/or control plasmid transfected control 
cells to determine fold change. 
 
2.6 TCF/LEF reporter assay 
 
Cells were transfected with pGL3-BARL, which is used as a readout for TCF 
activity and pRL-TK (transfection control). Cells were then treated with DMSO (vehicle 
control), 10-7 M RA, or co-transfected with Nox1 or Nox4 expression plasmids in equal 
amounts of DNA. Protein lysates were collected 3 days post-treatment or post-
transfection with a passive lysis buffer (Promega) contained in the Dual-Glo Luciferase 
Assay System and according to manufacturer's recommendations (Promega). Luciferase 
amount was quantified using the GloMax Multi Detection System (Promega) by 
measuring luminescence after treatment with Luciferase Assay Substrate for firefly 
luminescence and treatment with Stop & Glo® Reagent for Renilla luminescence. Values 
were presented as relative luminescence derived from the quotient of firefly 
luminescence (pGL3-BARL) and Renilla luminescence (pRL-TK). 
 
2.7 ROS detection 
 
Intracellular ROS was detected using 5-(and-6-)-chloromethyl-2',7'-
dichlorodihydrofluorescein diacetate prepared in DMSO (CM-H2DCFDA; Life 
Technologies, Invitrogen) and fluorescence microscopy. This ROS indicator works after 
cleavage of acetate groups within cells, and then oxidation of the nonfluorescent CM-
H2DCFDA produces the highly fluorescent 2’,7;dichlorofluroescein (DCF). Following 
treatment or transfection, cells were incubated with 2 µM CM-H2DCFDA and 10 µg/ml 
Hoechst 33342 (Molecular Probes, Life Technologies) in Hank’s Balanced Salt Solution 
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(Life Technologies, Invitrogen) for 15 min at 37°C and 5% CO2. Immediately after 
incubation, cells were rinsed twice with PBS and images were captured using a Zeiss 
Axio Observer A1 inverted microscope with a QImaging Retiga CCD.  
 
2.8 Statistical Analysis 
 
 Data from qRT-PCR, densitometric analysis of immunoblots and Luciferase 
assays were gathered from three independent biological replicates. Comparisons of data 
between control and experimental groups were performed using a one-way ANOVA with 
Tukey’s honest significant difference (HSD) post-hoc test or a Student’s t-Test (SPSS 
Statistics for Windows Version 19.0, IBM Corp. Released 2010, Armonk, NY). Student’s 
t-Test was used for statistical analysis of data when comparing control to only one 
experimental data set and * is used to denote significant difference. All other data was 
analyzed using a one-way ANOVA followed by Tukey’s HSD test and letters are used to 
indicate significant differences. P-values were considered statistically significant at the 





3.1 Overexpression of Gata6 increased Nox1 and Nox4 mRNA 
levels 
 
We have previously shown an increase in ROS levels, accompanied by increased 
expression of Nox1-4, during RA-mediated F9 cell differentiation [6]. Additionally, 
Gata6, a regulator of endoderm and extraembryonic endoderm formation, was 
upregulated in cells treated with RA, and when overexpressed alone, was sufficient to 
induce differentiation [38]. Furthermore, Adachi et al. (2008) showed in CaCo-2 cells 
that Gata6 was responsible for increased Nox1 transcription. This evidence led me to 
propose that GATA6 was responsible for the upregulation of Nox1 and Nox4 in F9 cells, 
leading to differentiation of PrE. To address this, I transiently overexpressed Gata6 and 
then analyzed Nox1 and Nox4 mRNA levels 4 days post transfection using qRT-PCR (Fig 
3.1). L14 primers were used to ensure equal loading control, and all data was analyzed 
using the delta/delta CT method to determine relative mRNA levels. As expected, Gata6 
steady state levels of mRNA were increased following Gata6 overexpression (P<0.05) 
(Fig 3.1A), and this was also sufficient to significantly increase (P < 0.05) the levels of 
Nox1 (Fig 3.1B) and Nox4 (Fig 3.1C) mRNA. Note that these levels were comparable 





Figure 3.1. GATA6 overexpression increased steady state levels of Nox1 and Nox4 
mRNAs. Total RNA was collected from F9 cells transfected with pcDNA3.1-EV 
(control) and treated with either DMSO or RA or transfected with pcDNA3.1-Gata6 and 
cultured for 4 days with 1.75 mg/ml G418. Collected RNA was reverse transcribed into 
cDNA and then processed for real time PCR. (A) Cells transfected with pcDNA3.1-
Gata6 showed increased mRNA of Gata6 when compared with EV transfected cells. (B) 
Cells transfected with pcDNA3.1-Gata6 and cells transfected with EV and treated with 
RA showed increased Nox1 mRNA when compared with DMSO treated cells transfected 
with EV. (C) Cells transfected with pcDNA3.1-Gata6 and cells transfected with EV with 
RA treatment showed increased Nox4 mRNA when compared with DMSO treated cells 
transfected with EV. Data are representative of three independent experiments. * denotes 

















3.2 Chemical inhibition of NOX attenuated F9 cell differentiation 
 
A role for ROS in PrE development was established in our lab, where it was 
shown that Diphenyleneiodonium chloride (DPI), a flavoenzyme inhibitor of ROS, 
attenuates RA-induced PrE differentiation [6]. DPI is frequently used to inhibit ROS 
production, but given the fact that it acts on numerous oxidoreductases, including the 
NOX family of proteins, an approach specifically targeted to the NOX family was needed 
[39]. Despite the fact that Nox genes in F9 cells are RA-responsive, the source of the 
ROS may not only come from the NOX proteins. To test the hypothesis that the activity 
of the NOX proteins is necessary for PrE differentiation, F9 cells were treated with NOX-
specific inhibitors and the mRNA knocked down using siRNAs specific to Nox1 and/or 4. 
First, the pan-NOX inhibitor, VAS2870 (Sigma) [40] was used to determine if members 
of the NOX family were necessary for F9 cells to differentiate to PrE. VAS2870 can 
inhibit all NOX isoforms, but it specifically targets NOX1, NOX2 [41] and NOX4 [42]. 
Moreover, VAS2870 does not serve as an antioxidant because it has no O2- scavenging 
effects [43]. Cells treated with DMSO, RA, or VAS2870 (1 μM) or co-treated with 
VAS2870 and RA (10-7 M) were analyzed using qRT-PCR for changes in Dab2, a 
marker of PrE (Fig 3.2). Results of Dab2 mRNA, relative to the loading control L14, 
showed no significant difference between DMSO, VAS2870 or VAS2870 and RA. The 
mRNA level of Dab2 in cells treated with RA was significantly different from the other 
three treatments (P<0.001) (Fig 3.2A). Immunoblot analysis with the TROMA-1 
antibody was used to detect increased KER8 levels characteristic of F9 cell induced to 
differentiate into PrE [44]. TROMA-1 signals on immunoblots were only seen following 
RA treatment (Fig 3.2B). Thus, inhibiting the NOX family of proteins attenuated RA-
mediated differentiation, and would indicate that NOX proteins were necessary for 
complete differentiation. 
 I extended these results to specifically examine the necessity of NOX1 and 
NOX4. The NOX1 specific inhibitor ML171 (Tocris) was used at the reported NOX1 
inhibition IC50 of 250 nM [43]. ML171 was reported to have no ROS scavenging effects 
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[43], making it an ideal candidate for determining specific involvement for NOX1 in F9 
cell PrE differentiation. The mRNA level of Dab2 in DMSO and ML171 treated cells 
was not significantly different from each other, but both were significantly different from 
RA treated cells (P<0.001) and cells co-treated with RA and ML171 (P<0.05) (Fig 3.2C). 
Furthermore, the Dab2 mRNA level in co-treated cells was also significantly different 
from that in RA treated cells (P<0.05) (Fig 3.2C). Immunoblot analysis with the 
TROMA-1 antibody was used to determine if ML171 treatment could block or reduce 
differentiation caused by RA. Unlike the RA treated controls, TROMA-1 was not 
detected in DMSO or ML171 treated cells (Fig 3.2D). Cells co-treated with ML171 and 
RA show reduced TROMA-1 signal (Fig 3.2D), indicating that the inhibition of NOX1 
activity attenuated RA-induced differentiation of PrE. NOX4 was not targeted since there 
was no known specific chemical inhibitor(s) that did not have ROS scavenging effects or 





Figure 3.2. PrE markers are attenuated following co-treatment of VAS2870 or 
ML171 with RA. (A) Total RNA was collected from F9 cells treated with DMSO, RA 
and/or VAS2870 (1 μM) 1 day post plating and cultured an additional 3 days. Collected 
RNA was reverse transcribed into cDNA and then processed for real time PCR. RA-
treated cells showed increased Dab2 mRNA when compared with cells treated with 
DMSO, VAS2870 or VAS2870 with RA. (B) Protein lysates were collected from F9 cells 
treated with DMSO, RA and/or VAS2870 (1 μM). Although immunoblot analysis with 
the TROMA-1 antibody showed signals in RA-treated cells, no signals were detected in 
cells treated with DMSO, VAS2870 alone or co-treated with RA and VAS2870. β-actin 
was used as a loading control. (C) Total RNA was collected from F9 cells treated with 
DMSO, RA and/or ML171 (250 nM) and cultured for 4 days. RA-treated cells showed 
increased Dab2 mRNA when compared with cells treated with DMSO, ML171 or 
ML171 with RA. Cells co-treated with ML171 and RA showed a significant increase in 
Dab2 mRNA when compared with DMSO and ML171 treated cells. (D) Protein lysates 
were collected from F9 cells treated with DMSO, RA and/or ML171. Immunoblot 
analysis with the TROMA-1 antibody showed signals in RA-treated cells, but not in cells 
treated with DMSO and ML171 alone. Cells co-treated with RA and ML171 show 
reduced TROMA-1 signals. β-actin was used as a loading control. Data are representative 
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3.3 Knockdown of Nox1 and/or Nox4 attenuated F9 cell 
differentiation 
 
To corroborate the chemical inhibitor data, F9 cells were transfected with an 
siRNA vector to knockdown Nox1 mRNA. Cells were also transfected with an siRNA 
vector to target Nox4, or transfected with a scrambled siRNA and treated with DMSO or 
RA as a negative and positive controls, respectively. Additionally, to test if knocking 
down Nox1 and Nox4 together would have a greater effect on blocking differentiation 
than the individual knockdowns, both siRNA vectors were transfected into cells. The 
results of the Nox1 knockdown are shown in Fig 3.3A, the steady state mRNA levels 
induced by RA was significantly lower in cells containing the siRNA targeting Nox1 
transcript (P<0.05). A significant reduction in Nox4 mRNA induced by RA was also seen 
(P<0.05) (Fig 3.3B). qRT-PCR analysis revealed that there was no significant difference 
in Dab2 mRNA between the scrambled siRNA transfected cells treated with DMSO, 
individual knockdowns treated with RA or Nox1 and Nox4 knocked down together and 
treated with RA (Fig 3.4A). As expected, there was a significant increase in Dab2 mRNA 
(P<0.05) in scrambled siRNA transfected cells treated with RA (Fig 3.4A). Finally, the 
knockdown of Nox1 and Nox4 together treated with RA show no significant difference in 
TROMA-1 levels when compared to the individual knockdowns treated with RA, or the 
scrambled siRNA treated with DMSO control and TROMA-1 levels were significantly 
higher in scrambled siRNA transfected cells treated with RA (P<0.05) (Fig 3.4B and Fig 





Figure 3.3. Knockdown of Nox1 and Nox4. Total RNA was collected from F9 cells 
transfected with si-scr, si-Nox1 and/or si-Nox4 and cultured 4 days with RA treatment 
and 1.0 µg/ml puromycin for selection. Collected RNA was reverse transcribed into 
cDNA and then processed for real time PCR. (A) Cell transfected with si-Nox1 and both 
si-Nox1 and si-Nox4 showed significantly decreased Nox1 mRNA when compared cells 
transfected with si-scr. (B) Cell transfected with si-Nox1 and both si-Nox1 and si-Nox4 
showed significantly decreased Nox4 mRNA when compared cells transfected with si-
scr. Data are representative of three independent experiments. Means with different 















Figure 3.4. Knockdown of Nox1 and Nox4 reduced the appearance of RA-mediated 
PrE markers. Total RNA and protein were collected from F9 cells transfected with si-
scr, si-Nox1 and/or si-Nox4 and cultured 4 days with RA treatment and 1.0 µg/ml 
puromycin for selection. Collected RNA was reverse transcribed into cDNA and then 
processed for real time PCR. (A) Relative Dab2 mRNA was significantly decreased in 
RA-treated cells transfected with si-Nox1 and/or si-Nox4 when compared with RA-
treated si-scr transfected cells. Dab2 mRNA in DMSO-treated cells transfected with si-
scr was not significantly different from RA-treated cells transfected with si-Nox1 and/or 
si-Nox4. (B, C) Protein lysates were collected from F9 cells transfected with si-scr, si-
Nox1 and/or si-Nox4 and treated with DMSO or RA for 4 days. Immunoblot analysis 
with the TROMA-1 antibody shows significantly decreased signal in RA-treated cells 
transfected with si-Nox1 and/or si-Nox4 when compared with RA-treated si-scr 
transfected cells. TROMA-1 levels in DMSO-treated cells transfected with si-scr were 
not significantly different from RA-treated cells transfected with si-Nox1 and/or si-Nox4. 
β-actin was used as a loading control. Data are representative of three independent 

















3.4 Overexpression of Nox1 and Nox4 did not induce F9 cell 
differentiation 
 
Given these results, together with the fact that H2O2 treatment induced F9 cells to 
differentiate into PrE [6, 17], it seemed logical to propose that Nox overexpression should 
also induce differentiation. To test whether or not Nox1 or Nox4 overexpression could 
induce differentiation, F9 cells were transfected with pcDNA3.1-EV and treated with 
either DMSO or RA or transfected with pcDNA3.1-Nox1 or 4. The relative degree of 
overexpression was determined by qRT-PCR, and results show an approximate 700 and 
1800 fold increase for Nox1 (Fig 3.5A) and Nox4 (Fig 3.5B), respectively. Despite the 
massive increase in Nox1 and Nox4 mRNA there was no obvious increase in cell death, 
although the latter was never measured. Once established that there was a significant 
increase in the levels of Nox1 and 4 mRNA in cells, it was necessary to examine if this 
increase translated into increased ROS levels. Transfected F9 cells were incubated with 2 
µM CM-H2DCFDA, as a ROS indicator, and 10 µg/ml Hoechst 33342 (Molecular 
Probes, Life Technologies) for nuclear staining. Cells transfected with pcDNA3.1-EV and 
treated with DMSO show little ROS fluorescence, whereas RA-treated cells and those 
transfected with either Nox1 or Nox4 show high levels of ROS (Fig 3.5C). As another 
positive control, cells were transfected with pcDNA3.1-EV and treated with H2O2 (Fig 
3.5C). As expected, these CM-H2DCFDA-containing cells show very strong ROS 
staining. Together, these data confirmed that ectopic expression of Nox1 or Nox4 
increased ROS levels in F9 cells. To determine if these increased levels in ROS could 
activate canonical WNT-β-catenin signaling, cells were co-transfected with Nox1 or 
Nox4, and the firefly luciferase reporter construct, pGL3-BARL, which contains 12 TCF-
binding sites upstream of a firefly luciferase gene, used as a readout for active canonical 
WNT signaling [45]. All cells were transfected with the Renilla luciferase construct, TK-
RL, to normalize for transfection efficiency of pGL3-BARL. Relative TCF activity can be 
determined by comparing the measured luminescence produced by the firefly luciferase 
activity relative to the luminescence produced by the transfection control Renilla 
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luciferase activity. As expected, results from RA-treated F9 cells transfected with 
pcDNA3.1-EV, showed a significant increase in TCF/LEF activity over the negative 
DMSO control (Fig 3.5D). Cells overexpressing Nox1 or Nox4 showed an increase in 
TCF/LEF activity, however, this increase was less than that seen in RA-treated cells, and 
was not significant from either RA or DMSO treatments (Fig 3.5D). Encouraged by the 
readout results for increased ROS and a trend for active WNT signaling, cells 
overexpressing Nox1 or Nox4 were then analyzed for PrE differentiation. qRT-PCR and 
immunoblot analysis, using Dab2 and TROMA-1, respectively, were used to confirm the 
differentiation of F9 cells to PrE. As expected, Dab2 mRNA level relative to the L14 
loading control was significantly higher in RA treated cells than DMSO treated cells 
(P<0.001) (Fig. 3.6A and Fig 3.6B). Dab2 mRNA, however, resulting from either the 
overexpression of Nox1 (Fig 3.6A) or Nox4 (Fig 3.6B) was not significantly different 
from that in DMSO treated cells (P>0.05), suggesting that differentiation had not 
occurred. That TROMA-1 signals were not seen in DMSO treated, Nox1 overexpressing, 
or Nox4 overexpressing cells, but were present in RA treated cells (Fig 3.6C), confirmed 
that PrE had not formed as a result of Nox overexpression. Thus, despite the fact that 
overexpressing Nox1 or Nox4 in F9 cells produces ROS, this did not lead to a significant 
increase in canonical WNT signaling, or a significantly appearance of PrE markers 
suggested that either the levels of ROS were not sufficient to induce differentiation or 





Figure 3.5. Overexpression of Nox1 and Nox4 increased intracellular ROS levels, but 
did not significantly increase TCF/LEF activation. Total RNA was collected from F9 
cells transfected with an empty vector (EV) control, pcDNA3.1-Nox1 or pcDNA3.1-Nox4 
and cultured for 4 days with G418 selection at 1.75 mg/ml. Collected RNA was reverse 
transcribed into cDNA and then processed for real time PCR. (A) Cells transfected with 
pcDNA3.1-Nox1 showed increased Nox1 mRNA when compared to cells transfected 
with the EV. (B) Likewise, cells transfected with pcDNA3.1-Nox4 showed increased 
Nox4 mRNA when compared to cells transfected with the EV. (C) F9 cells were 
transfected with pcDNA3.1-Nox1, or pcDNA3.1-Nox4 or transfected with an EV control 
and treated with DMSO or RA were cultured for 4 days, and then imaged using 2 µM 
CM-H2DCFDA to examine intracellular ROS and 10 µg/ml Hoechst 33342 (Molecular 
Probes, Life Technologies) to image nuclei. Cells transfected with EV were also treated 
with 100 µM H2O2 as a positive control and imaged following CM-H2DCFDA treatment. 
Cells transfected with the EV and treated with either RA or H2O2 and cells transfected 
with either pcDNA3.1-Nox1 or pcDNA3.1-Nox4 all show increased intracellular ROS 
when compared with cells transfected with the EV and treated with DMSO. (D) EV and 
pGL3-BARL transfected cells treated with RA show a significant increase in luciferase 
activity compared to that when cells were treated with DMSO. TCF activation in cells 
transfected with pcDNA3.1-Nox1 or pcDNA3.1-Nox4 showed no significant difference 
when compared to both RA and DMSO treated EV transfected cells. Data are 
representative of three independent experiments. Scale bar (30 µm). * denotes 






































3.6 Overexpression of Nox1 and Nox4 did not induce markers of PrE differentiation. 
Total RNA and protein were collected from F9 cells transfected with an empty vector 
(EV) control, pcDNA3.1-Nox1 or pcDNA3.1-Nox4 and cultured for 4 days with G418 
selection at 1.75 mg/ml. Collected RNA was reverse transcribed into cDNA and then 
processed for real time PCR. (A) Cells transfected with the EV and treated with RA 
showed increased Dab2 mRNA when compared with DMSO treated cells transfected 
with the EV and pcDNA3.1-Nox1 constructs. Dab2 mRNA in control cells was not 
significantly different from that seen in Nox1 transfected cells. (B) Cells transfected with 
the EV and treated with RA showed increased Dab2 mRNA when compared with that in 
DMSO treated cells transfected with the EV and pcDNA3.1-Nox4 constructs. Dab2 
mRNA in control cells was not significantly different from that seen in Nox4 transfected 
cells. (C) Protein lysates were collected from F9 cells transiently transfected with the EV, 
Nox1, or Nox4 or from cells treated with DMSO or with RA. Immunoblot analysis with 
the TROMA-1 antibody only shows signal in RA-treated cells. β-actin was used as a 
loading control. Data are representative of three independent experiments. Means with 





















4.1 WNT signaling and ROS in Differentiation 
 
The differentiation of F9 teratocarcinoma cells is dependent on the presence of 
ROS, the redox protein NRX, and the WNT signaling pathway [6, 9, 17]. Differentiation 
can be induced through direct manipulation of the aforementioned signaling molecules or 
proteins, but can also be induced through RA treatment or Gata6 overexpression [6, 9, 
17]. Additionally, in vivo cells of the ICM expressing Gata6 differentiate into PrE on 
E4.5 in the late blastocyst [3]. ROS and NRX work in tandem to augment the WNT 
pathway [18] and manipulation of them can affect the ability of F9 cells to differentiate 
[6, 9, 17]. F9 cells are used to recapitulate the differentiation of XEN in vitro [3, 6]. If the 
molecular changes seen when F9 cells differentiate in vitro also occur in vivo, we can 
reason that the ROS producing NOX family of proteins are important for the 
differentiation of the population of ICM cells that differentiate to PrE.  
WNT is important in three WNT pathways as well as being implicated in 
crosstalk with a variety of signaling pathways. The three WNT pathways are the WNT/β-
catenin pathway, Planar Cell Polarity (PCP) pathway, and WNT/Ca2+ pathway. DVL is 
present in all three WNT pathways, therefore NRX and ROS are negative and positive 
regulators respectively of PCP and WNT/Ca2+ pathways [6]. The WNT/β-catenin 
pathway is characterized by increased TCF/LEF activity due to β-catenin nuclear 
translocation, which is facilitated by FZD and DVL inhibiting a destruction complex in 
the presence of the WNT ligand. This pathway is implicated in both embryonic 
development and the progression of cancer [15, 45]. In PCP signaling, WNT activates the 
RHO-RAC-JNK pathway, through FZD and DVL, which occurs independently of β-
catenin [47]. The PCP pathway affects the cytoskeleton, and therefore cell morphology 
and migration [47]. Additionally, the PCP pathway directs the migration of F9 cells to a 
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PE-like lineage [48]. Investigation of the role of the PCP pathway in F9 cell 
differentiation was beyond the scope of my project, but given the information noted 
above, further investigation is warranted. Lastly, the WNT/Ca2+ is characterized by Ca2+ 
release from the endoplasmic reticulum due to activation of phospholipase C mediated 
through FZD and DVL [47]. Increased intracellular Ca2+ activates calcium/calmodulin-
dependent kinase II (CAMKII), which in turn leads to activation of Nemo-like kinase 
(NLK) antagonizing β-catenin/TCF-LEF signaling [47]. Despite these two additional, and 
possibly interacting pathways, the focus of my project was on the canonical WNT/β-
catenin pathway and the role of the NOX family of proteins. 
 Research in our lab, as well as that from others, shows that ROS have an intimate 
role in regulating the WNT/β-catenin pathway [17, 18]. WNT/β-catenin is redox 
regulated at the level of NRX binding to DVL and subsequently inhibiting WNT/β-
catenin signaling in the absence of ROS [17, 18]. In F9 cells, treatment with RA induces 
PrE differentiation and an increase in cytosolic ROS is observed [6]. Wen et al. (2012) 
show non co-localizing MitoTracker Red and CM-H2DCFDA, concluding that the source 
of ROS was likely not mitochondrial. Nox expression is also upregulated with RA 
treatment, providing a potential candidate for the cytosolic ROS production noted above 
[6]. Additionally, co-treatment with antioxidants or the general flavoenzyme inhibitor 
DPI attenuates RA-mediated PrE differentiation [6]. Together, this data indicates that 
ROS is integral to F9 cell PrE differentiation due to the interaction of NRX and DVL, 
and that NOX proteins could potentially be a factor in the production of ROS. 
 Our working hypothesis prior to this study proposed that RA activates WNT/β-
catenin signaling through many facets. First, RA upregulates Gata6, a transcription 
factor, which in turn leads to increased WNT6 and potentially NOX proteins, and an 
increase in ROS [6, 38, 49]. Increased ROS causes a dissociation of NRX from DVL [17, 
18], allowing the latter to be recruited to FZD at the plasma membrane and facilitate the 
disassembly of GSK-3β, AXIN, and the APC destruction complex. This disassembly 
allows β-catenin to accumulate and translocate to the nucleus where it associates with 
TCF-LEF to cause activation of WNT target genes necessary for F9 cell differentiation 
[38] (Fig 4.1). One question that arises, however, is why the need for negative regulation 
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of the WNT/β-catenin in the absence of the WNT ligand? Although many explanations 
are plausible, since an overexpression of Dvl can activate TCF-LEF and knockdown of 
Nrx induces PrE differentiation of F9 cells [17], we believe that NRX inhibiting DVL is a 
fail-safe mechanism to maintain low levels of WNT signaling. Additionally, G-protein 
coupled receptors (GPCRs), which includes FZD, have basal activity in the absence of 
ligand, indicating a need for negative regulation to prevent aberrant signaling [50]. This 
study aimed to determine if NOX1 and NOX4 play a role in augmenting the WNT/β-




Figure 4.1. A model of extraembryonic endoderm differentiation of F9 cells. RA 
binds RAR and RXR heterodimers, which in turn bind RA-response elements in the 
promoter region of RA-target genes. RA induces the expression of Gata6 leading to 
increased expression of Wnt6, Nox1 and Nox4. The increase in Nox1 and Nox4 leads to 
increased production of cytosolic ROS. This ROS oxidizes NRX, causing a dissociation 
of NRX and DVL. This dissociation, along with the presence of WNT6, enables FZD to 
recruit DVL, thereby inhibiting the AXIN-GSK-3β destruction complex leading to an 
accumulation of β-catenin. β-catenin translocates to the nucleus where it binds to 
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4.2 NOX1 and NOX4 in PrE differentiation 
 
 During RA-mediated F9 cell differentiation there is an increase in cytosolic ROS 
with a concomitant increase in the expression of Nox1-4 and Duox2 [6]. NOX4 is 
associated with cell proliferation, cytoskeletal reorganization, migration and stem cell 
differentiation [35, 36, 37]. Similarly, NOX1 has links to the WNT/β-catenin pathway 
and can post-transcriptionally increase the levels of Keratin 18 [32, 34]. Therefore, 
NOX1 and NOX4 were chosen as candidates for this study. Previous research has also 
shown that GATA6 directly binds the Nox1 proximal promoter [51] and an 
overexpression of Gata6 increases Nox4 expression in F9 cells [49]. My results show that 
an overexpression of Gata6 significantly increases Nox1 steady state mRNA levels when 
compared to DMSO treated control cells, and is not significantly different from RA 
treated cells. Furthermore, I confirmed that overexpressing Gata6 significantly increases 
Nox4 steady state mRNA levels when compared to DMSO treated control cells [49]; 
however, this increase was not significantly different from RA treated cells. Future 
studies involving ChIP analysis are needed to determine if GATA6 is bound to the Nox 
promoters and then by using PCR and DNA sequencing to analyze the prospective sites 
we can determine whether or not GATA6 is solely responsible for the increase in Nox1 
and Nox4 expression in F9 cells. If that is not the case, and to further prove that GATA6 
is responsible for Nox upregulation, Gata6 could be overexpressed and WNT signaling 
blocked using chemical inhibitors to determine if another pathway, independent of WNT, 
acts downstream of GATA6.  
 
4.3 NOX dependent differentiation of F9 cells 
 
 A previous study in the Kelly lab showed that ROS is necessary for PrE 
differentiation of F9 cells [6]. Unfortunately, a comprehensive NOX gene expression is 
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missing for most major model systems during development [51]. Weaver et al. (2016) 
showed that NOX proteins are expressed in zebrafish as early as 12h post-fertilization; 
however, XEN evolved in amniotes (reptiles, birds and mammals) [53]. Treating F9 cells 
with antioxidants or the non-specific flavoenzyme inhibitor DPI attenuates RA-mediated 
differentiation [6]. My study employs a more specific approach to targeting NOX 
proteins and the subsequent effect on PrE differentiation. My results showed that 
specifically inhibiting the NOX family, with VAS2870, attenuated RA-mediated 
TROMA-1 and Dab2 steady state mRNA levels. Thus, this data confirms that the NOX 
family is necessary for PrE differentiation and indicates it is most likely the major 
contributor of ROS production after RA treatment. Results in this study with the chemical 
inhibitor ML171 also revealed that NOX1 specifically is necessary for F9 cell 
differentiation. Furthermore, the genetic approach with siRNAs showed that the 
knockdown of Nox1 and Nox4 both individually and together resulted in attenuated 
differentiation, further adding support that NOX1 and NOX4 are necessary for F9 cells to 
form PrE. Although this data would indicate that the presence and functionality of both 
NOX1 and NOX4 are necessary for F9 cell PrE differentiation, further research into the 
roles of NOX2, NOX3, and DUOX2 in PrE differentiation is necessary to elucidate the 
specificity of ROS production by other NOX family members during differentiation. 
Also, additional studies are needed to determine if ROS, and potentially NOX1 and 
NOX4, play a role in PE differentiation. 
 
4.4 NOX1 and NOX4 produce ROS but not differentiated 
phenotype 
 
 The results of my study show an overexpression of either Nox1 or Nox4 produce 
ROS. Overexpressing Nox4 increases ROS in F9 cells [49] as well ROS production is 
known to be proportional to Nox4 expression [54]. Interestingly, it was previously shown 
that overexpressing Nox1 alone was sufficient to induce ROS production [55], but 
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subsequent studies have brought these results into question [24, 56]. This inconsistency in 
the literature could be cell line specific as evident in Banfi et al. (2003), who showed that 
co-overexpression of Nox1, p47phox and p67phox in HEK-293 cells produces superoxide 
following phorbol ester PMA treatment, but Nox1 overexpression alone with PMA 
treatment does not produce ROS. Additionally, the contradiction in the data for ROS 
production by Nox1 overexpression may also be due to the method of detection. DCFDA 
is a non-discriminatory ROS indicator, capable of detecting intracellular H2O2. Banfi et 
al. (2003) measured superoxide production and the possibility exists that the cytosolic 
superoxide produced by NOX1 was converted to H2O2 by superoxide dismutase and 
therefore not detected. In support, Suh et al. (1999) show Nox1 overexpression can 
produce superoxide and that it is reduced when in the presence of superoxide dismutase. 
Whether or not H2O2 was produced as a direct or indirect result of the Nox1 
overexpression was not the focus of my research. Nevertheless, this opens new avenues 
of research to determine if the expression patterns of additional NOX subunits prior to 
RA treatment change and if manipulating their expression, or their function, affects 
differentiation. 
Although the Nox1 and Nox4 overexpression in F9 cells produced ROS, it did not induce 
differentiation of these cells, which is unlike the treatment with exogenous H2O2 
previously shown by Wen et al. (2012). This could be explained by the concentration of 
ROS as the NOX proteins would produce ROS overtime, whereas the exogenous 
treatment would occur in a singular burst. Additionally, the overexpression of Nox1 and 
Nox4 produced an increased amount of TCF/LEF activity, however, this increase is not 
significant from either the positive control (RA) or negative control (DMSO) treated 
cells. This would indicate that there is a potential for the WNT/β-catenin pathway to be 
affected, at least to some degree, by the overexpression of Nox1 and Nox4 in F9 cells as 
shown in IEC-6 cells [32]. Perhaps the amount of ROS produced by overexpressing Nox1 
and Nox4 was not sufficient to oxidize enough NRX to induce differentiation. Previous 
research shows a knockdown of NRX is sufficient for differentiation [17]. Since the 
overexpression of Nox1 and Nox4 was not sufficient to induce differentiation, it is 
possible the threshold of basal GPCR activity of the FZD receptor was inhibited because 
NRX-DVL binding was maintaining cells in the undifferentiated state. Exogenous 
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treatment of H2O2 at 100 μM was, however, sufficient to facilitate DVL-NRX 
dissociation [6] and this I believe would allow basal FZD signaling to activate WNT/β-
catenin signaling required to differentiate F9 cells. In this regard, our model would 
suggest that in GATA6- and RA-mediated differentiation, the ROS produced by NOX1 
and NOX4 is sufficient to prime the WNT pathway and the presence of the WNT ligand 
in concert with ROS production would induce cells to form PrE. This could be tested if I 
were to overexpress Nox1 or Nox4 and then apply either sub-optimal concentrations of 
RA or Wnt6-conditioned media. 
 
4.5 Relationship of WNT and NOX in F9 cells 
 
 Overall, the data in this thesis provides cogent evidence that NOX1 and NOX4 
play an important role in WNT/β-catenin dependent F9 cell differentiation to PrE. In our 
model, WNT/β-catenin signaling is negatively regulated by NRX, at the level of DVL, 
and this fail-safe mechanism is removed in the presence of ROS [17]. The ROS 
producing proteins NOX1 and NOX4 were shown in this study to be downstream of the 
transcription factor GATA6 and necessary for PrE differentiation. That aberrant WNT 
signaling is prevalent in cancer biology [15, 46] underpins the importance of better 
understanding the regulation of WNT signaling and the role of ROS in both development 
and cancer research. My study not only helps to elucidate the regulation of how 
extraembryonic endoderm differentiates in mouse early development and the potential 
role of NOX proteins, but it also furthers our understanding of the crosstalk imparted by 
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